Glenn Crocker

Glenn Crocker

Glenn Crocker is CEO, BioCity Group. He has a first degree in Genetics and a D Phil in Immunology. He qualified as a chartered accountant with Ernst & Young and worked in the life science practice for a number of years, advising a range of businesses as well as editing and co-authoring a number of the firm’s US, European and Global Life Science Reports.

Glenn became CEO of BioCity Nottingham in 2003, growing it to be one of the largest bioscience incubators in Europe. He was a founder of R5 Pharmaceuticals, which was subsequently sold to Aesica, and he is a non-executive director of a number of other companies including Mobius Life Sciences, Xenogesis and Medilink East Midlands.